Dna X Inc (SONM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Sales | 63,992 | 116,251 | 135,665 | 0 | 0 |
| Cost of Goods | 48,781 | 81,742 | 87,576 | N/A | N/A |
| Gross Profit | 15,211 | 34,509 | 48,089 | N/A | N/A |
| Operating Expenses | 45,252 | 57,632 | 43,271 | 0 | 0 |
| Operating Income | -29,260 | -22,381 | 5,394 | N/A | N/A |
| Interest Expense | 759 | 1,522 | 1,828 | 0 | 0 |
| Other Income | -434 | -543 | -1,535 | 0 | 0 |
| Pre-tax Income | -30,453 | -24,446 | 2,031 | 0 | 0 |
| Income Tax | -521 | 1,388 | 754 | N/A | N/A |
| Net Income Continuous | -29,932 | -25,834 | 1,277 | N/A | N/A |
| Net Income | $-29,932 | $-25,834 | $1,277 | $N/A | $N/A |
| EPS Basic Total Ops | -1,165.47 | -2,500.00 | -4,622.30 | N/A | N/A |
| EPS Basic Continuous Ops | -1,165.00 | -2,497.53 | 666.31 | N/A | N/A |
| EPS Diluted Total Ops | -1,165.47 | -2,500.00 | -4,622.30 | N/A | N/A |
| EPS Diluted Continuous Ops | -1,165.00 | -2,497.53 | 666.31 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1,169.07 | -1,924.46 | N/A | N/A | N/A |
| EBITDA(a) | $-26,532 | $-18,856 | $7,244 | $N/A | $N/A |